Latest Breaking News On - Galectin therapeutics inc - Page 6 : comparemela.com

StockNews com Begins Coverage on Galectin Therapeutics (NASDAQ:GALT)

StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a report released on Sunday. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reissued a buy rating and issued a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, August 15th. Get Our […]

Virtu financialCitadel advisorsGalectin therapeutics incCentaurus financial incGalectin therapeuticsFree reportGet free reportTrail advisorsStreet groupTherapeutics incGalectin therapeutics dailyNasdaq galtInitiated coverageStocknews com

Galectin Therapeutics (NASDAQ:GALT) Now Covered by StockNews com

StockNews.com assumed coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research report released on Sunday morning. The brokerage issued a hold rating on the stock. Separately, HC Wainwright restated a buy rating and issued a $11.00 target price on shares of Galectin Therapeutics in a research note on Tuesday, August 15th. […]

Virtu financialGalectin therapeutics company profileCentaurus financial incGalectin therapeutics incCitadel advisorsGalectin therapeuticsFree reportGet free reportTrail advisorsStreet groupTherapeutics incGalectin therapeutics dailyNasdaq galtInitiated coverageStocknews com

Galectin Therapeutics to Participate in the H C Wainwright 7th Annual NASH Investor Conference on October 24, 2023

NORCROSS, Ga., Oct. 23, 2023 Galectin Therapeutics Inc. , the leading developer of therapeutics that target galectin proteins, announced today the Company will be participating in the H.C..

Jack callicuttPolf boudesInternational study evaluating the efficacyGalectin therapeutics incDrug administrationGlobenewswire incCompany contactGalectin therapeutic chief medical officerSeamless adaptive phasePlacebo controlled multicenterInternational study evaluatingEsophageal varicesCompany sponsored phaseFatty liver diseaseAdvanced fibrosisFast track

Galectin Therapeutics (GALT) Appoints Benjamin S Carson, Sr to its Board

Galectin Therapeutics (GALT) Appoints Benjamin S Carson, Sr to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Richarde uihleinBenjamins carsonGalectin therapeutics incGalectin therapeuticsJohns hopkins hospital

Galectin Therapeutics (NASDAQ:GALT) Receives New Coverage from Analysts at StockNews com

StockNews.com began coverage on shares of Galectin Therapeutics (NASDAQ:GALT – Free Report) in a research note issued to investors on Friday. The brokerage issued a hold rating on the stock. Separately, HC Wainwright reaffirmed a buy rating and issued a $11.00 target price on shares of Galectin Therapeutics in a research report on Tuesday, August […]

Geode capital managementOsaic holdings incGalectin therapeutics incAdvisor allianceNorthern trust corpGalectin therapeuticsFree reportGet free reportTrust corpTrail advisorsCapital managementIndependent advisor allianceTherapeutics incGalectin therapeutics dailyNasdaq galtInitiated coverage